E-MAIL: [email protected]
FDA has approved Skyclarys (omaveloxolone) as the first treatment for Friedreich’s ataxia, a rare, inherited, degenerative disease that damages the nervous system, characterized by impaired coor...
062023.03
For some high value-added drugs, whether the COP vial will change color after Gamma sterilization is also a key issue. one of...
032023.03
As a common packaging for antineoplastic drugs, the market demand for COP vials will also be driven.
272023.02
Disposable Intranasal Atomization Device can achieve better absorption and high bioavailability without flowing out from the n...
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
Reserved Powered by
MAKE AN ENQUIRY
